Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Dedicated

- PMLiVE

NHS Alliance policy director to collaborate with Packer Forbes

Michael Sobanja to offer advice on market access challenges

US doctors supportive of patients who track their health

But Manhattan Research study finds measurements used remain low-tech

- PMLiVE

Lifestyle choices of consumer health

A race has emerged between pharma and the consumer goods industries to stake claims on the consumer health market

- PMLiVE

Novo opens doors on new US headquarters

$225m redevelopment for New Jersey life science offices

Novartis day

Xolair gets asthma green light from NICE

Final guidance recommends Novartis drug for severe persistent asthma 

- PMLiVE

BMS wins wider NICE Orencia arthritis approval

But only after cutting the drug's price

- PMLiVE

AstraZeneca supports NHS medication passport app

Backs NIHR-NHS initiative under joint working agreement

Roche - Basel

Roche to shut Applied Science unit

170 jobs in the firing line as pharma company reorganises diagnostic presence

- PMLiVE

Former Pfizer exec Stephen Williams joins Venaxis board

Is current chief medical officer of SomaLogic

- PMLiVE

NICE set to hand Bayer wider recommendation for Xarelto

Backs drug’s use to treat pulmonary embolism and prevent DVT

- PMLiVE

Charting a sea change in medical education

The medical education landscape has changed significantly over recent years. There are many reasons for this sea change, but two stand out...

- PMLiVE

FDA approves Alcon eye drug Simbrinza

Fixed-combination licensed to treat glaucoma patients in the US

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links